Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Alternate sessions of transcranial direct current stimulation (tDCS) reduce chronic pain in women affected by chikungunya. A randomized clinical trial

Full text
Author(s):
Souza, Clecio Gabriel De [1, 2] ; Pegado, Rodrigo [2, 3] ; Costa, Jardson [4] ; Morya, Edgard [5, 3, 6] ; Baptisa, Abraha Fonte [7, 5, 3] ; Unal, Gozde [8] ; Bikson, Marom [8] ; Okano, Alexandre Hideki [7, 5, 3]
Total Authors: 8
Affiliation:
[1] Univ Fed Rio Grande do Norte, Grad Program Collect Hlth, Natal, RN - Brazil
[2] Univ Fed Rio Grande do Norte, Postgrad Program Rehabil Sci, Santa Cruz, RN - Brazil
[3] NAPeN Network Rede Nucl Assistencia & Pesquisa Ne, Belo Horizonte, MG - Brazil
[4] Fac Estacio Rio Grande Norte, Natal, RN - Brazil
[5] Univ Estadual Campinas, Brazilian Inst Neurosci & Neurotechnol BRAINN CEP, Campinas, SP - Brazil
[6] Santos Dumont Inst, Edmond & Lily Safra Int Neurosci Inst, Macaiba, RN - Brazil
[7] Univ Fed ABC, Ctr Math Comp & Cognit, Sao Bernardo Do Campo, SP - Brazil
[8] CUNY City Coll, Dept Biomed Engn, New York, NY - USA
Total Affiliations: 8
Document type: Journal article
Source: BRAIN STIMULATION; v. 14, n. 3, p. 541-548, MAY-JUN 2021.
Web of Science Citations: 0
Abstract

Context: Thousands of people worldwide have been infected by the chikungunya virus (CHIKV), and the persistence of joint pain symptoms has been considered the main problem. Neuromodulation techniques such as transcranial direct current stimulation (tDCS) act on brain areas involved in the processing of chronic pain. It was previously demonstrated that tDCS for five consecutive days significantly reduced pain in the chronic phase of chikungunya (CHIK). Objective: To analyze the effect of alternate tDCS sessions on pain and functional capacity in individuals affected by CHIK. Methods: In a randomized clinical trial, 58 women in the chronic phase of CHIK were divided into two groups: active-tDCS (M1-S0, 2 mA, 20 min) and sham-tDCS. The Visual Analogue Scale (VAS) and the Brief Pain Inventory (BPI) were used to assess pain, while the Health Assessment Questionnaire (HAQ) assessed functional capacity. These scales were used before and after six sessions of tDCS in nonconsecutive days on the primary motor cortex, and at follow-up consultation 7 and 15 days after the last session. A repeated measures mixed-model ANOVA was used for comparison between groups (significant p-values < 0.05). Results: A significant pain reduction (Z {[}3, 171] = 14.303; p < 0.0001) was observed in the tDCS group compared to the sham group; no significant difference in functional capacity was observed (Z {[}1.57] = 2.797; p = 0.1). Conclusion: Our results suggest that six nonconsecutive sessions of active tDCS on M1 reduce pain in chronic CHIKV arthralgia. (c) 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). (AU)

FAPESP's process: 13/07559-3 - BRAINN - The Brazilian Institute of Neuroscience and Neurotechnology
Grantee:Fernando Cendes
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC